Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
CRISPR-Cas9 is widely used to edit the genome by studying genes of interest and modifying disease-associated genes. However, this process is associated with side effects including unwanted mutations ...
Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at their genetic source.
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
CRISPR Therapeutics (NASDAQ: CRSP) works in the cutting-edge space of gene editing. The biotech company uses the CRISPR/Cas9 technique, which involves cutting DNA at a certain point and letting a ...
Vertex Pharmaceuticals is licensing CRISPR’s technology for its type 1 diabetes program. The deal involves an up-front payment, milestone payments -- and the potential for royalties down the road.
The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to new findings. The ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback